Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
445.80
-3.57 (-0.79%)
May 22, 2026, 1:23 PM EDT - Market open
Revenue Breakdown
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
Life Sciences Solutions Revenue | 10.67B | 10.37B | 9.63B | | | | | | | | | | | | |
Life Sciences Solutions Revenue Growth | 2.84% | 7.71% | -3.47% | | | | | | | | | | | | |
Analytical Instruments Revenue | 7.55B | 7.55B | 7.46B | | | | | | | | | | | | |
Analytical Instruments Revenue Growth | -0.03% | 1.22% | 2.75% | | | | | | | | | | | | |
Specialty Diagnostics Revenue | 4.67B | 4.68B | 4.51B | | | | | | | | | | | | |
Specialty Diagnostics Revenue Growth | -0.13% | 3.64% | 2.43% | | | | | | | | | | | | |
Laboratory Products and Biopharma Services Revenue | 24.38B | 23.98B | 23.16B | | | | | | | | | | | | |
Laboratory Products and Biopharma Services Revenue Growth | 1.65% | 3.57% | 0.50% | | | | | | | | | | | | |
| -2.07B | -2.03B | -1.88B | | | | | | | | | | | | |
| 45.20B | 44.56B | 42.88B | | | | | | | | | | | | |
| 1.44% | 3.91% | 0.05% | | | | | | | | | | | | |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
| 19.03B | 18.66B | 17.59B | | | | | | | | | | | | |
Consumables Revenue Growth | 1.97% | 6.12% | -0.06% | | | | | | | | | | | | |
| 7.23B | 7.30B | 7.45B | | | | | | | | | | | | |
Instruments Revenue Growth | -0.97% | -1.95% | -2.62% | | | | | | | | | | | | |
| 18.94B | 18.59B | 17.85B | | | | | | | | | | | | |
| 1.85% | 4.19% | 1.31% | | | | | | | | | | | | |
| 45.20B | 44.56B | 42.88B | | | | | | | | | | | | |
| 1.44% | 3.91% | 0.05% | | | | | | | | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
| 23.23B | 23.03B | 22.50B | | | | | | | | | | | | |
North America Revenue Growth | 0.83% | 2.35% | -1.14% | | | | | | | | | | | | |
| 12.16B | 11.83B | 10.86B | | | | | | | | | | | | |
| 2.82% | 8.92% | 1.08% | | | | | | | | | | | | |
| 8.18B | 8.10B | 7.96B | | | | | | | | | | | | |
Asia-Pacific Revenue Growth | 0.97% | 1.82% | 1.05% | | | | | | | | | | | | |
| 1.63B | 1.60B | 1.56B | | | | | | | | | | | | |
Other Regions Revenue Growth | 2.19% | 2.31% | 5.54% | | | | | | | | | | | | |
| 1.00M | -1.00M | 1.00M | | | | | | | | | | | | |
| 45.20B | 44.56B | 42.88B | | | | | | | | | | | | |
| 1.44% | 3.91% | 0.05% | | | | | | | | | | | | |
EBIT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
Life Sciences Solutions Operating Income | 3.89B | 3.77B | 3.50B | | | | | | | | | | | | |
Life Sciences Solutions Operating Income Growth | 3.16% | 7.56% | 2.43% | | | | | | | | | | | | |
Analytical Instruments Operating Income | 1.69B | 1.74B | 1.96B | | | | | | | | | | | | |
Analytical Instruments Operating Income Growth | -2.54% | -11.20% | 2.46% | | | | | | | | | | | | |
Specialty Diagnostics Operating Income | 1.26B | 1.26B | 1.16B | | | | | | | | | | | | |
Specialty Diagnostics Operating Income Growth | 0.64% | 8.37% | 3.11% | | | | | | | | | | | | |
Laboratory Products and Biopharma Services Operating Income | 3.40B | 3.35B | 3.09B | | | | | | | | | | | | |
Laboratory Products and Biopharma Services Operating Income Growth | 1.37% | 8.41% | -7.98% | | | | | | | | | | | | |
| -2.35B | -2.36B | -2.37B | | | | | | | | | | | | |
| 7.89B | 7.75B | 7.34B | | | | | | | | | | | | |
Operating Income (Total) Growth | 1.90% | 5.57% | 6.97% | | | | | | | | | | | | |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
Total Organic Revenue Growth | 2.00% | - | | | | | | | | | | | | |
Updated May 1, 2026. Data Source:
Fiscal.ai.
